Trial intelligence / Profile preview

PA21 with Calcium Carbonate in Hemodialysis

NCT01850641Phase 3Completed

Sponsor
Kissei Pharmaceutical Co., Ltd.
Start
Apr 2013
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of iron sucrose in hyperphosphatemia, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Apr 2013; status: completed.

02

Drugs

iron sucrose
03

Conditions

hyperphosphatemia

Beyond the preview

Go deeper on NCT01850641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01850641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call